Methotrexate-Induced Lymphoproliferative Disorder Complicating Into Spontaneous Tumor Lysis Syndrome and Disseminated Intravascular Coagulation

Lymphoproliferative disorder (LPD) is a severe adverse outcome of methotrexate (MTX) administration in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The immunosuppression caused is attributed to pathogenesis. Hence, discontinuation is the treatment. Reports on spont...

Descripción completa

Detalles Bibliográficos
Autores principales: Parajuli, Abinash, Chinnappan, Justine, Azher, Qazi, Bachuwa, Ghassan, Mcdonald, Philip J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356908/
https://www.ncbi.nlm.nih.gov/pubmed/37485199
http://dx.doi.org/10.7759/cureus.40665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356908/
https://www.ncbi.nlm.nih.gov/pubmed/37485199
http://dx.doi.org/10.7759/cureus.40665

Ejemplares similares